BackChina Pharma Holdings Overview

China Pharma Holdings Other Liabilities

Latest other liabilities for CPHI: $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

China Pharma Holdings Other Liabilities History

Loading

China Pharma Holdings vs. peers: Other Liabilities Comparison

Loading

China Pharma Holdings Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

China Pharma Holdings (CPHI) FAQ

China Pharma Holdings (CPHI) currently reports a other liabilities of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore China Pharma Holdings's other liabilities history and peer comparisons.

China Pharma Holdings's other liabilities changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

China Pharma Holdings reported $0 in other liabilities as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for China Pharma Holdings, and consider following CPHI for alerts when major investors trade the stock.

China Pharma Holdings is classified in the Healthcare sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CPHI with unrelated industries.